Alternate-Day Buprenorphine Administration. Phase I - 3

Clinical Trial ID NCT00000221

PubWeight™ 1.20‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00000221

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clustering clinical trials with similar eligibility criteria features. J Biomed Inform 2014 1.18
2 Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sci 1994 0.98
Next 100